FDA approves St. Jude’s safety-enhanced devices

The FDA approved next-generation implantable defibrillators that offer new safety and performance features.

Minneapolis-based St. Jude Medical announced its Ellipse and SJM Assura family of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds) include an algorithm that ensures therapy is delivered in the event of an electrical short and a low-friction coating on the device that can reduce friction between the device and leads.

A past analysis of some Durata leads had found abrasions and abrasions that resulted in high-voltage failures. St. Jude recalled its Riata and Riata ST silicone leads in late 2011 due to insulation failures.

The Ellipse and Assura portfolio of ICDs and CRT-Ds received CE mark in Europe in May.

Candace Stuart, Contributor

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup